makes sense to me. I was thinking we'd hit $5 by Nov-ish - and then shoot to $10 following an EUA, ideally by YE. However, i don't really know what the lag / timing would be between hitting our PE in the Brazil trial and getting an EUA? I would hope it's quick. And then of course, how will the US FDA respond?

Weird as it sounds, once we get that first approval, the SP becomes less and less of my focus. Because at that point, we're in a different league. Revenue producing company with an approved drug.

What will be really fun, will be the totally new class of investors who come plowing in following our uplisting. Tons of wealthy individuals and institutions (who are prohibited from OTC stocks) will pile in, which of course will only drive the price higher.

While it seems to some of us like we've been here forever, we're still in the very early innings of this game. And i think it's going to be a helluva fun game!